• Thumbnail for Molnupiravir
    Molnupiravir, sold under the brand name Lagevrio, is an antiviral medication that inhibits the replication of certain RNA viruses. It is used to treat...
    53 KB (4,211 words) - 08:34, 9 July 2024
  • Thumbnail for PANORAMIC trial
    preexisting health condition. The antivirals tested in the study will be molnupiravir and nirmatrelvir/ritonavir (Paxlovid). In December 2022, results from...
    6 KB (525 words) - 08:27, 20 October 2023
  • the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along...
    7 KB (525 words) - 02:06, 31 July 2024
  • Thumbnail for Feline infectious peritonitis
    of Cyprus, on 8 August 2023 the government released 80,000 anti-COVID molnupiravir pills from its national COVID-19 stockpile, in a bid to solve the feline...
    26 KB (2,878 words) - 20:13, 28 August 2024
  • being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
    67 KB (6,361 words) - 06:35, 1 September 2024
  • Thumbnail for AGILE
    include molnupiravir, high-dose nitazoxanide, the monoclonal antibody Vir 7832, intravenous favipiravir, and the combination of molnupiravir plus nirmatrelvir/ritonavir...
    8 KB (878 words) - 05:24, 13 July 2024
  • Thumbnail for COVID-19 drug development
    molnupiravir's mutagenic effects could create new variants that evade immunity and prolong the COVID‑19 pandemic. In September 2023, molnupiravir's mutagenicity...
    90 KB (13,103 words) - 04:28, 26 July 2024
  • Thumbnail for COVID-19 pandemic
    adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
    368 KB (32,633 words) - 18:22, 1 September 2024
  • Thumbnail for COVID-19
    being actively studied in clinical trials. These include the antivirals molnupiravir (developed by Merck), and nirmatrelvir/ritonavir (developed by Pfizer)...
    288 KB (33,181 words) - 04:15, 26 August 2024
  • health and nutrition products including the oral anti covid medication Molnupiravir & Nirmatrelvir co-packaged with Ritonavir and injectable Remdesivir....
    4 KB (256 words) - 13:52, 6 June 2024
  • Minaprine Mirtazapine Misoprostol - Hospital authorization only. Moclobemide Molnupiravir Moperone Naloxone Naltrexone Nefazodone Nialamide Isobutyl nitrite Nomifensine...
    26 KB (1,685 words) - 02:08, 21 February 2024
  • Thumbnail for Xavier-Luc Duval
    revealed that private firm MERCK was the sole importer of anti-COVID drugs Molnupiravir and Ronapreve on the island of Mauritius. Kailesh Jagutpal further revealed...
    20 KB (2,148 words) - 12:30, 20 August 2024
  • in funding to help develop Molnupiravir. Merck & Co. partnered with Ridgeback to perform clinical trials with Molnupiravir in humans to treat COVID-19...
    6 KB (547 words) - 14:35, 30 October 2023
  • Thumbnail for Merck & Co.
    treat millions of people in countries such as Yemen and African nations. Molnupiravir is an antiviral pill to treat COVID-19, developed in partnership with...
    96 KB (9,405 words) - 01:48, 1 September 2024
  • HIV Loviride HIV Maraviroc HIV entry inhibitor Methisazone Smallpox Molnupiravir COVID-19 viral RNA polymerase inhibitor Moroxydine Influenza Nelfinavir...
    13 KB (513 words) - 14:31, 4 May 2024
  • COVID-19 antivirals including paxlovid (nirmatrelvir/ritonavir) and molnupiravir on acute COVID-19 outcomes and long COVID. Including work which evaluated...
    13 KB (1,293 words) - 18:00, 6 August 2024
  • Thumbnail for Responses to the COVID-19 pandemic in October 2021
    Government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. The Malaysian Deputy Education Minister...
    25 KB (1,876 words) - 05:06, 24 June 2024
  • Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Remdesivir Co-packaged Nirmatrelvir ritonavir...
    180 KB (23,898 words) - 14:59, 19 August 2024
  • Thumbnail for Viral disease
    (SARS-CoV-2) Coronaviridae droplet contact coronavirus disease 2019 (COVID-19) Molnupiravir, Nirmatrelvir/ritonavir hand washing covering mouth when coughing or...
    36 KB (1,249 words) - 10:35, 10 July 2024
  • Thumbnail for Ensitrelvir
    of other antiviral drugs targeting COVID-19, including remdesivir and molnupiravir. In a study of 428 patients, viral load was reduced, but symptoms were...
    16 KB (1,126 words) - 09:51, 6 August 2024
  • Merck Sharp & Dohme (MSD) to purchase the experimental antiviral pill molnupiravir. If approved by Medsafe, Pharmac will be supplied with 60,000 courses...
    266 KB (17,636 words) - 02:44, 13 July 2024
  • Thumbnail for Responses to the COVID-19 pandemic in July 2022
    for vulnerable patients to obtain a range of drugs including paxlovid, molnupiravir, and remdesivir. Timeline of the COVID-19 pandemic in July 2022 Responses...
    3 KB (200 words) - 23:00, 28 August 2024
  • Thumbnail for COVID-19 drug repurposing research
    different standard than the other big pharma trials, with Paxlovid and molnupiravir and the monoclonals. Acetylcysteine is being considered as a possible...
    128 KB (14,900 words) - 02:57, 1 September 2024
  • Thumbnail for Isko Moreno
    government unit in the country to procure anti-COVID-19 medicines such as Molnupiravir, Remdesivir, Tocilizumab, Baricitinib, and Bexovid for aged 12 and above...
    183 KB (16,018 words) - 09:05, 29 August 2024
  • Thumbnail for Bemnifosbuvir
    relative hospitalization risk by 71%. Galidesivir Remdesivir Lufotrelvir Molnupiravir Sofosbuvir Berliba E, Bogus M, Vanhoutte F, Berghmans PJ, Good SS, Moussa...
    5 KB (414 words) - 02:31, 18 February 2024
  • of the replication inhibition of the corona virus by Remdesivir and Molnupiravir 2004 Roche Symposium Award (Leading chemists of the next decade), Basel...
    9 KB (984 words) - 03:35, 22 May 2024
  • government was negotiating with Merck & Co to procure stocks of its antiviral molnupiravir pills for treating COVID-19. Under the Movement Control Order put in...
    221 KB (16,305 words) - 16:25, 19 August 2024
  • Thumbnail for Timeline of the COVID-19 pandemic in 2023
    adjusted its treatment guidelines. Among other changes, remdesivir and molnupiravir were now recommended only for the most severe cases, and deuremidevir...
    173 KB (16,237 words) - 17:50, 1 September 2024
  • Thumbnail for Rick Bright
    additional federal funding to Ridgeback Biotherapeutics to further develop molnupiravir into a treatment for COVID-19. He argued that although the drug had shown...
    31 KB (2,760 words) - 02:44, 2 July 2024
  • marketing authorisation, to Promomed, for Esperavir, a drug based on molnupiravir and developed for the treatment of COVID-19. In April 2022, Ministry...
    17 KB (1,269 words) - 09:55, 6 May 2024